Trials / Completed
CompletedNCT03070717
High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 153 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research project intends to observe patients with high myopia who show pathological retinal changes, in order to evaluate more data on the risk factors for developing mCNV within this research project population in Germany.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Observation & Diagnosis | SD-OCT, fundus autofluorescence, fundus photography, optional microperimetry, ophthalmic exams (BCVA, optical biometry), blood sampling. |
Timeline
- Start date
- 2014-06-12
- Primary completion
- 2019-05-23
- Completion
- 2019-05-23
- First posted
- 2017-03-03
- Last updated
- 2019-07-19
Locations
26 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03070717. Inclusion in this directory is not an endorsement.